✦ LIBER ✦

Synchronous bilateral breast cancer in a male patient following hormone therapy for prostate cancer

✍ Scribed by Yuko Kijima; Heiji Yoshinaka; Munetsugu Hirata; Yoshihisa Umekita; Sumika Matsukita; Takashi Arima; Masayuki Nakagawa; Hizuru Kumemura; Nobuo Hamada; Koichi Kaneko; Yawara Funasako; Shoji Natsugoe

Publisher: Springer
Year: 2009
Tongue: English
Weight: 397 KB
Volume: 14
Category: Article
ISSN: 1341-9625
DOI: 10.1007/s10147-008-0824-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Feasibility of Breast Conservation Thera

Feasibility of Breast Conservation Therapy in Metachronous or Synchronous Bilateral Breast Cancer

✍ Keith M. Heaton; George E. Peoples; S. Eva Singletary; Barry W. Feig; Merrick I. 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 106 KB

Successful use of letrozole in male brea

Successful use of letrozole in male breast cancer: A case report and review of hormonal therapy for male breast cancer

✍ Brent P. Zabolotny; Christian V. Zalai; Sarkis H. Meterissian 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB

Intermittent docetaxel therapy with estr

Intermittent docetaxel therapy with estramustine for hormone-refractory prostate cancer in Japanese patients

✍ Norihito Soga; Manabu Kato; Kouhei Nishikawa; Yoshihiro Hasegawa; Yasushi Yamada 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 305 KB

Gene therapy for human prostate cancer.

Gene therapy for human prostate cancer. Translational research in the hormone refractory dunning prostate cancer model

✍ Michael A. Carducci; Sujatha R. Ayyagari; Martin G. Sanda; Jonathan W. Simons 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 833 KB

Possibility of recovery of estrogen sens

Possibility of recovery of estrogen sensitivity following high-dose glucocorticoid therapy in a patient with hormone-refractory prostate cancer

✍ Shinya Yamamoto; Jyunji Yonese; Satoru Kawakami; Tetsuro Tsukamoto; Yuhei Ohkubo 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 620 KB

Initial decline in hemoglobin during neo

Initial decline in hemoglobin during neoadjuvant hormonal therapy predicts for early prostate specific antigen failure following radiation and hormonal therapy for patients with intermediate and high-risk prostate cancer

✍ Anthony V. D'Amico; Tara Saegaert; Ming-Hui Chen; Andrew A. Renshaw; Daniel Geor 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB 👁 1 views

## Abstract ## BACKGROUND Declines in serum hemoglobin (Hgb) levels occur from the use of androgen suppression therapy (AST) in the treatment of prostate cancer patients. We studied whether time to prostate specific antigen (PSA) failure following external beam radiation therapy (RT) and AST could